News Tivicay approved in Europe in new dispersible tablet for chi... ViiV’s Tivicay is to become available in Europe in a new dispersible tablet form to treat children living with HIV.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
